fda import alert glp-1 semaglutide tirzepatide green list Medications for Weight Loss: vs vs Retat – Revolution Health & Wellness FDA's green list cracks down

Retatrutide won't be available until 20272028 at the earliest

Its often said that medications dont work in the long term without lifestyle changes and indeed, clinical trials of these meds always include diet and exercise education [intermountainhealthcare.org]

Others tolerate faster increases

concluded that semaglutide is at highest risk of being abused, misused, and used without a prescription, compared to other GLP-1 analogs

MYB superfamily in brassica napus: evidence for hormone-mediated expression profiles, large expansion, and functions in root hair development

The concern is that this "benefit" becomes a liability with excessive dosing or prolonged cycles